Cannlabs (CANL) Stock Price, News & Analysis

Company Overview

CannLabs, Inc. provides cannabis testing laboratory services in the United States. Its testing services include potency testing, residual solvent analysis, microbiological testing, pesticide testing, heavy metals testing, nutrient analysis, terpenes analysis, shelf-life/stability studies, gene expression testing, and genotyping/phenotyping testing. The company also offers data/analytics and consulting, as well as education services. CannLabs, Inc. was incorporated in 2010 and is based in Denver, Colorado.

Key Stats

• Today's Range: $0.0001 to $0.0001
• 50-Day Range: N/A
• 52-Week Range: $0.0001 to $0.01
• Volume: 2,320 shs
• Average Volume: 1,695 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CANL Stock Analysis - Frequently Asked Questions

How have CANL shares performed this year?

Cannlabs' stock was trading at $0.0001 at the start of the year. Since then, CANL shares have increased by 0.0% and is now trading at $0.0001.

How do I buy shares of Cannlabs?

Shares of CANL stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Cannlabs own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannlabs investors own include Ginkgo Bioworks (DNA), RTX (RTX), Vapor Group (VPOR), Arbor Realty Trust (ABR), Ambev (ABEV), AbbVie (ABBV) and Advance Auto Parts (AAP).

Company Calendar

• Today: 8/25/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:CANL
• CIK: N/A
• Web: www.cannlabs.com
• Phone: (512) 568-5062
• Fax: N/A
• Employees: 37
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: 1.60